March 2, 2022 in News | Comments Off on Job Opening: Vice President Research & Development
You have a strong passion for making a novel product/technology into a commercial success.
We are looking for a commercially driven VP R&D with a background from Life Science/medtech/biotech. You have demonstrated results from similar type role, i.e leading R&D organization in comparable business/industry of novel technology as well as from product launch in a global marketplace
You are passionate about R&D and being part of a growth company with insight and experience with R&D documentation standards and experienced working with external stakeholders (regulators, customers, R&D labs)
Furthermore, you are eager to develop colleagues and team, both personally and professionally.
At Amicoat, we value personal integrity and strive for the highest professional standards in our team.
The ideal candidate will be a highly motivated individual with experience from and interest in working in a small, entrepreneurial environment with broad responsibilities and opportunities.
We offer
This recruitment is carried out in collaboration with the recruitment company Borka Consulting AS.
If you have any questions regarding Amicoat or the position, feel free to contact our recruitment advisor in Borka Consulting; André Borka at +47 908 31 871.
Please send your application (both motivational letter and CV in PDF format) to andre@borka.no.
Norwegian applicants may apply in Norwegian.
All inquiries are treated confidentially, also towards Amicoat in the initial phase if desired.
We look forward to receiving your application!
Amicoat AS is a Norwegian biotechnology company that discovers, develops, and commercializes novel antimicrobial science with broad applications across diverse industries. Our current focus is on medical equipment, and we are also exploring utilization of our technology in other industries. With our origins above the Arctic Circle in the city of Tromsø in Northern Norway, we aspire to be a leading company in the antimicrobial coating industry, providing our clients with tailored antimicrobial coating solutions. Our primary product, AMC-109, offers a reliable and environmentally safe antimicrobial solution addressing needs across a wide range of industries. AMC-109 is backed by extensive data demonstrating efficacy and safety, and inducing antimicrobial activity with minimal environmental impact. Efficacy has also been demonstrated with viruses and fungi. More info at www.amicoat.com.
Contact person: André Borka
Title: Headhunter – Life sciences
Mobile: 908 31 871
Nettverk: LinkedIn
Job Opening: Vice President Research & Development
Amicoat is heading towards an exciting phase where we want to strengthen our technology and. . .
Read moreNy sjef med drømmebakgrunn
Selskapet Amicoat i Forskningsparken produserer et bakteriedrepende stoff som er forsket frem ved Universitetet i. . .
Read moreAmicoat Media Inquiries
Amicoat AS
Oslo Science Park
Lensmannslia 4
1386 Asker, Norway
media: media@amicoat.com
Contact UsAmicoat will not pass on your contact information to third parties or use the contact information provided for purposes other than keeping you informed about company news.
An email confirmation will be sent to you shortly. If your internet provider filters incoming emails, please add media@amicoat.com to your list of approved senders to ensure that you receive the newsletter.